Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Ligand Pharmaceuticals Incorporated, commonly referred to as Ligand, is a prominent biopharmaceutical company headquartered in the United States. Founded in 1992, Ligand has established itself as a leader in the life sciences industry, focusing on the development of innovative therapies and drug discovery solutions. The company operates primarily in the United States, with significant influence in global markets.
Ligand's core business areas include the development of proprietary drug candidates and the licensing of its extensive portfolio of drug discovery technologies. Notable products such as the Captisol® technology, which enhances the solubility and stability of pharmaceutical compounds, set Ligand apart in the competitive landscape. With a strong market position, Ligand has achieved numerous milestones, including strategic partnerships with major pharmaceutical companies, solidifying its reputation as a key player in advancing healthcare solutions.
-22 vs industry average
Ligand Pharmaceuticals Incorporated’s score of 18 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Ligand Pharmaceuticals Incorporated yet.
Ligand Pharmaceuticals Incorporated, headquartered in the US, currently does not have available carbon emissions data for the most recent year. As such, there are no specific figures regarding their Scope 1, Scope 2, or Scope 3 emissions. Additionally, the company has not outlined any formal reduction targets or commitments to climate initiatives, such as those from the Science Based Targets initiative (SBTi) or other industry-standard frameworks.
Without emissions data or reduction commitments, it is unclear how Ligand Pharmaceuticals is addressing climate change within its operations. The absence of reported emissions and targets suggests a potential area for improvement in transparency and accountability regarding their environmental impact.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for Ligand Pharmaceuticals Incorporated yet.
No scope 3 category breakdown has been disclosed yet.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more